Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zomedica Corp. Common Shares (NY:ZOM)

0.0973 UNCHANGED
Last Price Updated: 8:00 PM EST, Mar 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0973
Bid (Size) 0.0970 (13)
Ask (Size) 0.0984 (2)
Prev. Close 0.0973
Today's Range 0.0973 - 0.0973
52wk Range 0.0943 - 0.1677
Shares Outstanding 979,949,668
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Zomedica Announces Strategic PulseVet(R) Shock Wave Partnership with World Equestrian Center – Ocala
Via ACCESS Newswire
Zomedica Announces Issuance of Additional Patent for its TRUVIEW(R) Microscope
Via ACCESS Newswire

Performance

YTD
-29.6%
-29.6%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
-24.7%
-24.7%
1 Year
-36.5%
-36.5%

More News

Read More
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUFORMA Diagnostic Platform(R) - Revolutionizing In-Clinic Diagnostics
Via ACCESS Newswire
Zomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA(R) Diagnostic Platform Featuring an Extended Range and Automatic Sample Dilution
Via ACCESS Newswire
Zomedica Unveils Exclusive Fourth Friday at Four Webinar Series to Explore Cutting-Edge Veterinary Innovations
Via ACCESS Newswire
Zomedica Corp. Announces Transition to OTCQB Venture Market
Via ACCESS Newswire
Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters
Via ACCESS Newswire
Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis
Via ACCESS Newswire
Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market
Via ACCESSWIRE
Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy
Via ACCESS Newswire
Earnings Scheduled For March 13, 2025
Via Benzinga
Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone
Via ACCESSWIRE
Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer
Via ACCESSWIRE
Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET
Via ACCESS Newswire
Zomedica Unveils New Canine Tests Offering Faster Diagnostics for Heart and Breeding Health
Via Benzinga
Zomedica Corp (NYSE: ZOM) Featured in Coverage of NobleCon20
Via Investor Brand Network
Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024
Via ACCESSWIRE
Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform
Via ACCESSWIRE
Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform
Via ACCESSWIRE
Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal Conference
Via ACCESSWIRE
Larry Heaton, CEO of Zomedica Corp. (NYSE: ZOM), to Present at NobleCon20
Via Investor Brand Network
Noble Capital Markets Initiates Equity Research Coverage on Zomedica
Via ACCESSWIRE
Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024
Via ACCESSWIRE
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth
Via ACCESSWIRE
Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET
Via ACCESSWIRE

Frequently Asked Questions

Is Zomedica Corp. Common Shares publicly traded?
Yes, Zomedica Corp. Common Shares is publicly traded.
What exchange does Zomedica Corp. Common Shares trade on?
Zomedica Corp. Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Zomedica Corp. Common Shares?
The ticker symbol for Zomedica Corp. Common Shares is ZOM on the New York Stock Exchange
What is the current price of Zomedica Corp. Common Shares?
The current price of Zomedica Corp. Common Shares is 0.0973
When was Zomedica Corp. Common Shares last traded?
The last trade of Zomedica Corp. Common Shares was at 03/04/25 08:00 PM ET
What is the market capitalization of Zomedica Corp. Common Shares?
The market capitalization of Zomedica Corp. Common Shares is 95.35M
How many shares of Zomedica Corp. Common Shares are outstanding?
Zomedica Corp. Common Shares has 95M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.